Therapeutic targeting of eukaryotic initiation factor (eIF) 4E

Biochem Soc Trans. 2023 Feb 27;51(1):113-124. doi: 10.1042/BST20220285.

Abstract

Fundamental studies unraveled the role of eukaryotic initiation factor (eIF) 4E in mRNA translation and its control. Under physiological conditions, regulation of translation by eIF4E is essential to cellular homeostasis. Under stress, gene flow information is parsed by eIF4E to support adaptive mechanisms that favor cell survival. Dysregulated eIF4E activity fuels tumor formation and progression and modulates response to therapy. Thus, there has been heightened interest in understanding eIF4E function in controlling gene expression as well as developing strategies to block its activity to treat disease.

Keywords: cancer therapy; eIF4F; translational control.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Eukaryotic Initiation Factor-4E* / genetics
  • Eukaryotic Initiation Factor-4E* / metabolism
  • Humans
  • Neoplasms*
  • Peptide Initiation Factors / genetics
  • Peptide Initiation Factors / metabolism
  • Phosphorylation

Substances

  • Eukaryotic Initiation Factor-4E
  • Peptide Initiation Factors

Grants and funding